Brindlecote Insurance Brokers / B-Brain – Renewal
Callcompleted
Brindlecote Insurance Brokers: documents · 2026-04-27 11:15
Daniel Okafor and Nell Ashcombe offered Brindlecote a like-for-like Starter renewal at £19,500. Ravi Atherton, Ed Duckworth and Zoe Nuttall raised no blockers; Ravi wants to review the paperwork before signing.
What was said
What this says
Current to 11 Oct 26Daniel Okafor and Nell Ashcombe offered Brindlecote a like-for-like Starter renewal at £19,500. Ravi Atherton, Ed Duckworth and Zoe Nuttall raised no blockers; Ravi wants to review the paperwork before signing.
What happened: Daniel opened the renewal conversation and Nell confirmed same tier, same price, one-year term. Zoe asked about invoicing and was told the invoice arrives the morning the contract starts.
Customer view: Ed said people are asking questions on their own, which was not happening before. Ravi said the team is getting value.
Commercial: Ed asked about Growth. Nell advised Starter is the right fit while only the renewals team uses the brain, and left Growth for a later renewal or anytime in between.
Watch: Nothing was signed on the call, and Ravi wants to read the paperwork first. Use is confined to the renewals team, which Ed says is most of the current user base.
Themes
Current to 9 Oct 26Who was there
B-Brain
Them
Follow-up
Next steps
Current to 9 Oct 26- Daniel Okafor sends the renewal order form to Ravi Atherton that week.
- Daniel Okafor gives Ed Duckworth what he needs to share the renewal internally.
- Zoe Nuttall expects the invoice on the morning the new term starts.
Risks
Current to 9 Oct 26- The order form was not signed on the call and Ravi Atherton wants to review it first.
- Use sits with the renewals team and a couple of others, so the value case is narrow.
- Ed Duckworth wants to share the renewal details with his team before everyone is comfortable.
Opportunities
Current to 9 Oct 26- Ed Duckworth asked about Growth, which gives 40 users, 8 connectors and the dashboards builder.
- Other teams in the business do not yet know about the brain, which leaves room for a wider rollout.